Novartis & Roche
6 shared events · Importance 4 · Last updated Jun 14, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Novartis: Novartis is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Roche: Roche is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
International
Novartis: Novartis is a key investor, announcing two U.S. projects: a biomedical research center in San Diego and a cancer-drug production facility in Texas.
Roche: Roche is expanding its output in North Carolina as part of the Swiss investment surge.
Jun 07, 2026 · 7 articles
Tech
Novartis: Novartis was an attendee at the summit, suggesting its engagement with digital health technologies for clinical trials.
Roche: Roche was an attendee at the summit, indicating its presence in the digital biomarkers space and potential interest in technologies like 'CART BP pro'.
Jul 03, 2026 · 8 articles
Business
Novartis: Novartis is mentioned as a previous employer of Ian Marks, providing context for his experience but not directly affected by the event.
Roche: Roche is mentioned as a previous employer of Ian Marks, providing context for his experience but not directly affected by the event.
Aug 10, 2026 · 6 articles
Business
Novartis: Dhavalkumar Patel>>> spent 10 years at Novartis>>> as Head of Research for NIBR Europe.
Roche: Roche>>> acquired Inflazome>>> in 2020.
Jun 12, 2026 · 6 articles
Domestic
Novartis: Novartis>>> shed 0.3%-0.7% in one session but moved up by 1.85% in another, showing mixed performance in the Switzerland>>> market.
Roche: Roche>>> posted modest gains, contributing to the overall positive sentiment in the Switzerland>>> market.
May 21, 2026 · 8 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Novartis and Roche interact across events, view sentiment trends, and discover connected entities.
Open Dashboard